🔗 Permalink

Inventor profile of:

Christopher Breder

City:

Greenwich, Connecticut

Country:

United States

Published Applications:

Last publication date:

2015-08-27

Top Assignees for applications by Christopher Breder

The entities that hold a legal rights for patent applications filed by inventor Breder Christopher:

Purdue Pharma L.P. 18 Stamford, CT United States
Purdue Pharmaceuticals L.P. 10 Wilson, NC United States
The P.F. Laboratories, Inc. 10 Totowa, NJ United States
Euro-Celtique S.A. 2 Luxembourg, Luxembourg
THE P.F. LABORATORIES 2 Totowa, NJ United States

Recent patent applications by Breder Christopher

Christopher Breder from Greenwich, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-08-27

US20150238481A1

Human necessities

Pharmaceutical formulation containing gelling agent

#2 | 2015-05-28

US20150148319A1

Human necessities

Pharmaceutical formulation containing gelling agent

#3 | 2014-10-02

US20140296276A1

Human necessities

SEQUESTERED ANTAGONIST FORMULATIONS

#4 | 2014-04-10

US20140099376A2

Human necessities

Sequestered antagonist formulations

#5 | 2013-11-14

US20130303494A1

Human necessities

Pharmaceutical formulation containing gelling agent

#6 | 2013-10-03

US20130261145A1

Human necessities

Pharmaceutical formulation containing gelling agent

#7 | 2013-10-03

US20130261144A1

Human necessities

Pharmaceutical formulation containing gelling agent

#8 | 2013-10-03

US20130261143A1

Human necessities

Pharmaceutical formulation containing gelling agent

#9 | 2013-09-26

US20130251812A1

Human necessities

SEQUESTERED ANTAGONIST FORMULATIONS

#10 | 2013-09-19

US20130245055A1

Human necessities

Pharmaceutical formulation containing gelling agent

#11 | 2013-08-22

US20130217716A1

Human necessities

Pharmaceutical formulation containing gelling agent

#12 | 2012-11-15

US20120288567A1

Human necessities

Opioid agonist formulations with releasable and sequestered antagonist

#13 | 2012-05-03

US20120108622A1

Human necessities

Pharmaceutical formulation containing gelling agent

#14 | 2011-09-22

US20110230510A1

Human necessities

Pharmaceutical formulations containing opioid agonist, opioid antagonist and gelling agent

#15 | 2011-03-29

US10213919

Opioid agonist formulations with releasable and sequestered antagonist

#16 | 2010-11-30

US10214413

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

#17 | 2010-07-01

US20100168148A1

Human necessities

Pharmaceutical formulation containing gelling agent

#18 | 2009-03-26

US20090081287A1

Human necessities

Pharmaceutical composition containing gelling agent

#19 | 2006-12-05

US10213921

Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent

#20 | 2006-11-28

US10213920

Pharmaceutical formulation containing bittering agent

#21 | 2006-08-17

US20060182801A1

Human necessities

Sequestered antagonist formulations

InventorID:

403453 ⎘